Micro Medical this week announced that it received CE Mark approval for its long over-the-wire balloon catheter and MicroStent vascular stent.
MicroStent and MicroBalloon XL are part of the company’s MMS Micro Vascular Integrated Platform and are designed to achieve and maintain vessel latency and improve blood flow to reduce below-the-knee amputations for patients that have critical limb ischemia from peripheral artery disease.
“We’re very pleased to receive CE Mark approval for both the 2.5 mm MicroStent and 150 cm MicroBalloon XL,” CEO Gregory Sullivan said in a news release. “By expanding our portfolio of interventional devices, we are broadening the base of patients with CLI whom we can treat to avoid a life-altering below-the-knee amputation.”
MicroStent has been available in diameters of 3.0-4.5 mm, but is now available for vessels as small as 2.5 mm. It is also available in lengths of 8 mm, 15 mm, 25 mm, 40 mm and 60 mm. The longer 150 cm MicroBalloon XL allows surgeons to take a contralateral or ipsilateral approach to treatment.
